Gene Therapy, Luxturna™, Has Just Been Approved By The USA Food And Drug Administration (FDA) For Treating A Rare Hereditary Disease That Causes Blindness Disorder. This Is The First Gene Therapy Approved By The FDA For Treating A Genetic Disease. Hopefully, The Procedure Is Affordable To Everyone That Needs It.
Luxturna gene therapy to cost $425,000 per eye – CNNA one-time treatment with Luxturna, the first FDA-approved gene therapy for an inherited disorder, will cost $425,000 per eye.